Menu

Marinus Pharmaceuticals, Inc. MRNS

Full chart Compare
Set alert

Price alert · MRNS

All alert types
0.55 0.00 (+0.00%)

At closeFeb 10, 2025, 4:00 PM EST

0.5492 Day range 0.55

52-week range unavailable

YTD
+2.78%
1 year
-94.49%

Revenue & Expenses

Other Income → Expenses: $5.44MIncome Tax Benefit → Expenses: $1.54MExpenses → Selling, General & Admin: $61.15MExpenses → Research & Development: $99.39MExpenses → Interest Expense: $16.89MGross Profit → Expenses: $29.05MRevenue → Gross Profit: $29.05MRevenue → Cost of Revenue: $1.93MNet Loss → Expenses: $141.41MOther Income$5.44MIncome Tax Benefit$1.54MGross Profit$29.05MNet Loss$141.41MCost of Revenue$1.93MExpenses$177.44MSelling, General & Admin$61.15MResearch & Development$99.39MInterest Expense$16.89MRevenue$30.99M

Latest period ending Dec 31, 2023 · select a line to chart its full history

MRNS annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
30.99M25.48M15.35M1.72M0
29.05M25.14M13.87M1.72M0
-131.49M-112.79M-96.93M-67.94M-54.48M
-141.41M-19.82M-98.78M-67.47M-54.12M
-2.63-0.51-2.69-2.80-3.97
MRNS annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
120.57M240.55M122.93M138.51M90.94M
170.91M259.52M136.84M150.46M98.84M
154.14M143.52M83.35M13.26M11.07M
108.95M101.89M40.81M00
16.77M116.00M53.49M137.20M59.57M
MRNS annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-118.00M-112.89M-55.48M-60.91M-48.63M
-28.61M105.77M-1.42M-738.00K3.88M
26.63M124.74M41.31M109.22M67.97M
-110.00K-1.60M-2.89M0-388.00K
-119.98M117.62M-15.58M47.57M23.22M